We are live on ! Find out more
BGA

Belmont Global Advisors Portfolio holdings

AUM $106M
1-Year Est. Return 2.89%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
-2.89%
3 Year Est. Return
+81.05%
5 Year Est. Return
10 Year Est. Return
AUM
$139M
AUM Growth
+$19.6M
Cap. Flow
+$11.3M
Cap. Flow %
8.14%
Top 10 Hldgs %
36.55%
Holding
158
New
47
Increased
25
Reduced
35
Closed
29

Sector Composition

Rank Sector Weight
1 Energy 46.63%
2 Healthcare 18.69%
3 Technology 9.38%
4 Industrials 7.44%
5 Communication Services 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLK icon
151
State Street Technology Select Sector SPDR ETF
XLK
$114B
-29,000
Closed -$527K
XYL icon
152
Xylem
XYL
$28.6B
-19,000
Closed -$692K
VMW
153
DELISTED
VMware, Inc
VMW
-5,000
Closed -$540K
PGNX
154
DELISTED
Progenics Pharmaceuticals Inc
PGNX
-75,000
Closed -$307K
AYR
155
DELISTED
Aircastle Ltd
AYR
-13,325
Closed -$258K
OAK
156
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
-5,000
Closed -$291K
APL
157
DELISTED
ATLAS PIPELINE PARTNERS LP UTS
APL
-10,300
Closed -$331K
MRGE
158
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
-250,000
Closed -$610K

Similar funds

Belmont Global Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Belmont Global Advisors held 158 positions worth $139M, up 16% from $119M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Belmont Global Advisors deployed $11.3M of net new capital in Q2 2014, opening 47 new positions and adding to 25 existing holdings. Its largest new stake was ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE): 36,350 shares worth $1.63M.

By sector, the portfolio is most concentrated in Energy at 47% of assets, up from 36% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alaunos Therapeutics, an estimated $1.8M trimmed.

  • Belmont Global Advisors's largest Q2 2014 buy was ATLAS ENERGY L P COM UNITS REPSTG LTD PARTNER INT (DE): 36,350 shares worth $1.63M.
  • Belmont Global Advisors added most to Precigen in Q2 2014, an estimated $2.88M increase.
  • Belmont Global Advisors's biggest Q2 2014 reduction was Alaunos Therapeutics, cutting an estimated $1.8M.
  • Belmont Global Advisors fully exited KKR & Co in Q2 2014, selling an estimated $1.78M.
  • Belmont Global Advisors's ten largest holdings make up 37% of its $139M portfolio in Q2 2014.
  • Belmont Global Advisors opened 47 new positions and closed 29 in Q2 2014.
  • Belmont Global Advisors's portfolio value rose 16% quarter-over-quarter to $139M.

Based on Belmont Global Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.